A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies

Rheumatology (Oxford). 2017 Sep 1;56(9):1633. doi: 10.1093/rheumatology/kex266.

Xavier Bossuyt^{1

2}, Niels Rasmussen³, Pieter van Paassen⁴, Bernard Hellmich^{5

6}, Bo Baslund⁷, Pieter Vermeersch^{2

8}, Daniel Blockmans^{1

9}, Jan-Willem Cohen Tervaert¹⁰, Elena Csernok^{5

6}, Jan Damoiseaux¹¹

¹ Department of Microbiology and Immunology, KU Leuven.
² Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
³ Department of Autoimmunology and Biomarkers, Statens Seruminstitute, Copenhagen, Denmark.
⁴ Department of Internal Medicine, Section Nephrology and Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
⁵ Department of Internal Medicine, Rheumatology and Immunology, University Teaching Hospital Kirchheim.
⁶ Vasculitis-Center Tübingen-Kirchheim, Kirchheim, Germany.
⁷ Department of Rheumatology, Rigshospitalet, Copenhagen, Denmark.
⁸ Department of Cardiovascular Sciences, KU Leuven.
⁹ General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
¹⁰ Faculty of Health, Medicine and Life Sciences, Maastricht University.
¹¹ Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands.

No abstract available

Publication types